Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA.
Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA
J Bacteriol. 2020 Nov 19;202(24). doi: 10.1128/JB.00452-20.
Lipoprotein transport from the inner to the outer membrane, carried out by the Lol machinery, is essential for the biogenesis of the Gram-negative cell envelope and, consequently, for bacterial viability. Recently, small molecule inhibitors of the Lol system in have been identified and shown to inhibit the growth of this organism by interfering with the function of the LolCDE complex. Analysis of the transcriptome of treated with one such molecule (compound 2) revealed that a number of envelope stress response pathways were induced in response to LolCDE inhibition. However, is refractory to inhibition by the same small molecule, but we could demonstrate that could be substituted for the orthologues, where it functions in the correct transport of lipoproteins, and the cells are inhibited by the more potent compound 2A. In the present study, we took advantage of the functionality of LolCDE in and determined the transcriptional response to LolCDE inhibition by compound 2A. We identified key genes that responded to LolCDE inhibition and also demonstrated that the same genes appeared to be affected by genetic depletion of the native LolCDE proteins. Several of the major changes were in an upregulated cluster of genes that encode determinants of alginate biosynthesis and transport, and the levels of alginate were found to be increased either by treatment with the small molecule inhibitor or upon depletion of native LolCDE. Finally, we tested several antibiotics with differing mechanisms of action to identify potential specific reporter genes for the further development of compounds that would inhibit the native Lol system. A key set of lipoprotein transport components, LolCDE, were inhibited by both a small molecule as well as genetic downregulation of their expression. The data show a unique signature in the transcriptome in response to perturbation of outer membrane biogenesis. In addition, we demonstrate a transcriptional response in key genes with marked specificity compared to several antibiotic classes with different mechanisms of action. As a result of this work, we identified genes that could be of potential use as biomarkers in a cell-based screen for novel antibiotic inhibitors of lipoprotein transport in .
脂蛋白从内膜到外膜的转运是由 Lol 机器完成的,对于革兰氏阴性细胞包膜的生物发生是必不可少的,因此对于细菌的生存能力也是必不可少的。最近,已经鉴定出能够抑制 Lol 系统的小分子抑制剂,并通过干扰 LolCDE 复合物的功能显示出抑制该生物体生长的作用。用一种这样的分子(化合物 2)处理的转录组分析表明,许多包膜应激反应途径被诱导以响应 LolCDE 抑制。然而,对相同的小分子抑制不敏感,但我们可以证明可以用替代同源物,其中它在正确的脂蛋白转运中起作用,并且细胞被更有效的化合物 2A 抑制。在本研究中,我们利用了在中的 LolCDE 功能,并通过化合物 2A 测定了 LolCDE 抑制的转录反应。我们确定了对 LolCDE 抑制有反应的关键基因,并证明相同的基因似乎受到天然 LolCDE 蛋白遗传缺失的影响。几个主要的变化是在一个上调的基因簇中,该基因簇编码藻酸盐生物合成和转运的决定因素,并且通过用小分子抑制剂处理或耗尽天然 LolCDE,发现藻酸盐的水平增加。最后,我们测试了几种具有不同作用机制的抗生素,以确定可用于进一步开发抑制天然 Lol 系统的化合物的潜在特定报告基因。一组关键的脂蛋白转运成分 LolCDE 被小分子以及其表达的遗传下调所抑制。该数据显示了在外膜生物发生受到干扰时在转录组中出现的独特特征。此外,与具有不同作用机制的几种抗生素类相比,我们在关键基因中显示出明显的特异性转录反应。由于这项工作,我们确定了一些基因,这些基因可能作为基于细胞的筛选的潜在生物标志物,用于筛选新型脂蛋白转运抑制剂。